Menotropins
- Generic Name
- Menotropins
- Brand Names
- Menopur
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 9002-68-0
- Unique Ingredient Identifier
- 8FYM5179QJ
- Background
Menotropins contains follicle stimulating hormone (FSH) and luteinizing hormone (LH) purified from the urine of postmenopausal women. It is used as a fertility medication that is injected either subcutaneously or intramuscularly. It is composed of LH with 2 subunits, alpha = 92 residues, beta = 121 residues and FSH with 2 subunits, alpha = 92 residues, beta=111 residues.
- Indication
For the treatment of female infertility
- Associated Conditions
- -
- Associated Therapies
- Assisted Reproductive Technology therapy
Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)
- Conditions
- Infertility
- Interventions
- Drug: MenotrophinDrug: Follitrophin alphaDrug: CetrorelixDrug: ChoriongonadotropinDrug: Progesterone
- First Posted Date
- 2010-10-21
- Last Posted Date
- 2014-03-14
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 124
- Registration Number
- NCT01225835
- Locations
- 🇩🇪
IVF Zentrum, Saar, Germany
🇩🇪Endokrinologikum Ulm, Ulm, Germany
🇩🇪Fertility Center Berlin, Berlin, Germany
Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)
- Conditions
- Polycystic Ovarian SyndromeInfertility
- Interventions
- First Posted Date
- 2008-12-10
- Last Posted Date
- 2012-01-27
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 110
- Registration Number
- NCT00805935
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
🇺🇸Women & Infants' Hospital of RI, Providence, Rhode Island, United States
🇺🇸Conceptions Reproductive Associates of Colorado, Littleton, Colorado, United States
MENOPUR® Versus FOLLISTIM®
- Conditions
- Infertility
- Interventions
- Drug: MenotropinDrug: Progestrone vaginal insertDrug: Progesterone in oilDrug: follitropin betaDrug: Ganirelix
- First Posted Date
- 2008-12-04
- Last Posted Date
- 2011-11-02
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 173
- Registration Number
- NCT00802360
- Locations
- 🇺🇸
A Woman's Center for Reproductive Medicine, Baton Rouge, Louisiana, United States
🇺🇸Huntington Reproductive Center, Pasadena, California, United States
🇺🇸Women's Medical Research Group, LLC, Clearwater, Florida, United States
A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa
- First Posted Date
- 2005-11-23
- Last Posted Date
- 2010-02-26
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 80
- Registration Number
- NCT00257556
- Locations
- 🇬🇧
The Royal Hallamshire Hospital, University of Sheffield, Jessop Wing, Tree Root Walk, Sheffield, United Kingdom
🇬🇧Leeds General Infirmary, Great George Street, Leeds, United Kingdom
🇩🇪Gemeinschaftspraxis und Tagesklinik, Zingel 29, Hildesheim, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.